NR4A1 and breast carcinoma: Information on clinical data that could influence the prognosis of patients with a breast cancer was not available, namely stage at FPC and SPC diagnosis, hormonal receptor status of the tumor, treatment regime, as well as menopausal status, family history or genetic susceptibility.